Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (491-500 of 546) with videos related to

Pageof 55
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenibOsman Öcal, Kerstin Schütte, Christoph J Zech, et al.
BMC Cancer|May 1, 2020
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapyAnn-Kathrin Oehus, Stephanie G C Kroeze, Nina-Sophie Schmidt-Hegemann, et al.
EMBO Molecular Medicine|May 25, 2019
Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolismJulia K Götzl, Matthias Brendel, Georg Werner, et al.
Frontiers in Aging Neuroscience|February 19, 2021
Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's DiseaseAnnika Kreuzer, Julia Sauerbeck, Maximilian Scheifele, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2014
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controlsWalter Koch, Marcus Unterrainer, Guoming Xiong, et al.
Journal of Medicinal Chemistry|July 12, 2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-HumanVadim Bernard-Gauthier, Justin J Bailey, Andrew V Mossine, et al.
Brain Sciences|February 25, 2022
Impact of Partial Volume Correction on [<sup>18</sup>F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal SyndromeSebastian Schuster, Leonie Beyer, Carla Palleis, et al.
Biomedicines|May 28, 2022
Total Tumor Volume on <sup>18</sup>F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with <sup>225</sup>Ac-PSMA-I&TLena M Unterrainer, Leonie Beyer, Mathias J Zacherl, et al.
Frontiers in Oncology|December 6, 2021
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic OutlookMaximilian A Kirchner, Adrien Holzgreve, Matthias Brendel, et al.
Cancers|January 11, 2022
Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in GliomasLena Kaiser, Adrien Holzgreve, Stefanie Quach, et al.
Pageof 55

Showing results (491-500 of 546) with videos related to

Sort By:
Pageof 55
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenibOsman Öcal, Kerstin Schütte, Christoph J Zech, et al.
BMC Cancer|May 1, 2020
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapyAnn-Kathrin Oehus, Stephanie G C Kroeze, Nina-Sophie Schmidt-Hegemann, et al.
EMBO Molecular Medicine|May 25, 2019
Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolismJulia K Götzl, Matthias Brendel, Georg Werner, et al.
Frontiers in Aging Neuroscience|February 19, 2021
Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's DiseaseAnnika Kreuzer, Julia Sauerbeck, Maximilian Scheifele, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2014
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controlsWalter Koch, Marcus Unterrainer, Guoming Xiong, et al.
Journal of Medicinal Chemistry|July 12, 2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-HumanVadim Bernard-Gauthier, Justin J Bailey, Andrew V Mossine, et al.
Brain Sciences|February 25, 2022
Impact of Partial Volume Correction on [<sup>18</sup>F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal SyndromeSebastian Schuster, Leonie Beyer, Carla Palleis, et al.
Biomedicines|May 28, 2022
Total Tumor Volume on <sup>18</sup>F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with <sup>225</sup>Ac-PSMA-I&TLena M Unterrainer, Leonie Beyer, Mathias J Zacherl, et al.
Frontiers in Oncology|December 6, 2021
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic OutlookMaximilian A Kirchner, Adrien Holzgreve, Matthias Brendel, et al.
Cancers|January 11, 2022
Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in GliomasLena Kaiser, Adrien Holzgreve, Stefanie Quach, et al.
Pageof 55